Opus Point Partners Management, LLC - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$1,136,000
+48.7%
308,569
+211.7%
2.71%
+358.9%
Q1 2016$764,000
-29.2%
99,000
-1.0%
0.59%
-17.1%
Q4 2015$1,079,000
+47.2%
100,000
-5.8%
0.71%
+76.0%
Q3 2015$733,000
+24.0%
106,104
+59.1%
0.40%
-13.5%
Q2 2015$591,000
-10.2%
66,7040.0%0.47%
-15.1%
Q1 2015$658,000
+7.3%
66,704
+33.4%
0.55%
-9.2%
Q4 2014$613,00050,0000.61%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders